To assess the inflammatory potential of TNF-α on other pro-inflammatory cytokines, we conducted a neutralization assay using a TNF-α monoclonal antibody during activation of CD4+ T cells from T2DM patients. Here, CD4 is linked to type 2 diabetes mellitus.